Virtual Digital Histopathology with Explainable Deep Learning for Prostate Cancer Diagnosis
Project Number1R21CA294195-01
Contact PI/Project LeaderSHAH, PRATIK
Awardee OrganizationUNIVERSITY OF CALIFORNIA-IRVINE
Description
Abstract Text
Project Summary
Adoption of digital histopathology has increased demands for gigapixel image analysis tools and methods for
clinical applications. Integration of deep learning algorithms for automated tumor segmentation and cancer
diagnosis from Hematoxylin and Eosin (H&E) dye or virtual (stainless) staining of tissue biopsy images have
been reported. There is a significant lack of explanation and performance evaluation (black box phenomenon)
of tumor segmentation and stainless staining deep learning models limiting clinician adoption in oncology
practice. Results from these deep learning systems are known after the biopsy is irreversibly processed by
H&E staining, and do not include confirmatory immunohistochemistry (IHC) biomarker staining diagnosis
performed on adjacent tissue sections. We have previously described deep neural network systems to convert
native nonstained whole slide prostate tissue biopsy images (WSI) to virtual computationally H&E stained
versions validated for tumor segmentation with high precision. The goal of this proposal is developing novel
methods and algorithms for pixel-by-pixel explanations to clinicians and cancer researchers for explainability of
virtual H&E staining augmented with prostate tumor grade segmentation and IHC expression patterns by deep
learning models for digital biopsies. Our previously published and physician authenticated Generative
Adversarial Neural Network (GAN-CS) models trained with 93,199 image pairs of prostate biopsy images for
virtual H&E staining and prostate tumor segmentations, and a publicly available database of clinically validated
IHC analysis of prostate biopsy images will be used to generate the explainability software. A histological map
that visualizes and interprets correspondence between neural representations in GAN-CS model with virtually
stained prostate Gleason grade tumors in WSI at a pixel level will be generated. A separate explainable GAN-
CSS model for segmentation and Gleason grading of tumors using clinician annotations from H&E and
conjunctive IHC image biomarker labels will also be generated. Researchers can upload WSI into GAN-CS/S
software to perform computational H&E staining multiplexed with morphological tumor segmentations and IHC
expression with pixel-by-pixel visualization and explanation to characterize cellular phenotypes for cancer
research and accelerate histopathology diagnoses. The open source software toolkit developed from this
research can be generalized to majority of deep learning model architectures using disease labels from widely
available non-stained, chemical, or virtual H&E and IHC stained images from different cancer types.
Public Health Relevance Statement
Project Narrative
Stainless staining of tissue biopsy images and subsequent tumor segmentation by deep learning models is a
rapidly emerging technology for cancer research and histopathology diagnoses. We will develop new methods
and algorithms to generate knowledge-driven visualization and pixel-by-pixel explanations from clinically
validated deep learning models for virtual and chemical H&E and IHC staining to characterize cellular
phenotypes for cancer research and accelerate histopathology diagnoses.
No Sub Projects information available for 1R21CA294195-01
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 1R21CA294195-01
Patents
No Patents information available for 1R21CA294195-01
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 1R21CA294195-01
Clinical Studies
No Clinical Studies information available for 1R21CA294195-01
News and More
Related News Releases
No news release information available for 1R21CA294195-01
History
No Historical information available for 1R21CA294195-01
Similar Projects
No Similar Projects information available for 1R21CA294195-01